Keeping meals simple and balanced improves comfort after your first injection
For medical coding GLP-1 medications, accurate coding, documentation, and payer compliance are essential to avoid denials, audits, and recoupments
Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)
Janese Laster, a gastroenterologist and obesity medicine specialist in Washington, D.C
Injection-site and dermatologic reactions associated with glucagon-like peptide-1 receptor agonists: Insights from meta-analysis of randomised controlled trials and real-world evidence